▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / MDNC

MDNC — Medinotec Inc.

—
OTC · Health Care · Health Care Equipment & Supplies · CIK 1931055 · South Africa
Last close
$5.00
Market Cap
$58.78M
52W High
$5.00
52W Low
$5.00
ADV30
0
Next earnings
—
Medinotec Inc. engages in the research and development, production, and sale of medical devices used in cardiology and airway-related procedures in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, and silicone tracheal stents; and distributes a range of cardiology and renal dialysis products. It serves hospitals, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations. The company sells its products through the network of distributors and direct sales force. Medinotec Inc. was incorporated in 2021 and is headquartered in Johannesburg, South Africa.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Feb 2026 1,822,138 854,557 -264,222 -69,259 6,812,888 2,757,024 1,101,693
Nov 2025 2,536,994 1,346,052 552,712 403,411 6,852,928 2,856,926 1,352,691
May 2025 2,134,026 925,331 277,457 113,784 7,404,026 1,950,876 3,035,204
Feb 2025 3,525,162 2,386,320 1,998,970 1,477,209 6,808,973 2,769,686 2,538,144

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-218,024
Investing CF
$-17
Financing CF
$-91,332
CapEx
$-72,626
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.07
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$1,712,617
Inventory
$1,236,373
Receivables
$2,372,870
ST Investments
—
EBIT TTM
$2,531,086
Pretax Income TTM
$2,455,856
Interest Exp TTM
$75,230
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$9,729,463
EBITDA
$1,175,385
Free Cash Flow
$417,842
Enterprise Value
$56,036,120
Total Cash
$2,757,024
Total Debt
$15,406
Shares Out
11,755,548
Trailing EPS
$0.18
Book Value
$0.49
ROE
15.9%
ROA
10.0%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Feb 2026 9,729,463 1,094,512 794,502 6,812,888 1,101,693 — 906,798
Feb 2025 9,113,607 3,191,499 2,159,473 6,808,973 2,538,144 — 877,834
Feb 2024 5,020,391 -41,434 -404,688 4,804,279 2,637,108 — 14,242
Feb 2023 999,579 -238,587 -352,735 4,490,432 1,934,377 — -490,549

Peers — same industry

TickerNameMarket CapLastDaily %
POSC POSITRON CORP $57.81M $1.76 —
MDAI Spectral AI, Inc. $57.60M $1.81 —
HCIL Hongchang International Co., Ltd $60.70M $0.12 —
XTNT Xtant Medical Holdings, Inc. $61.28M $0.44 —
MYO MYOMO, INC. $54.87M $1.42 —

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →